Researchers will present the first-ever study of fractures and calcium pyrophosphate deposition disease at ACR Convergence 2023, the American College of Rheumatology's (ACR) annual meeting. They ...
Please provide your email address to receive an email when new articles are posted on . Among the many unanswered questions about calcium pyrophosphate deposition — formerly called “pseudogout” — ...
Researchers have discovered two genes, RNF144B and ENPP1, that cause calcium pyrophosphate deposition (CPPD) disease in Americans of European and African descent. This crystalline arthritis is caused ...
Calcium pyrophosphate deposition (CPPD) disease is a common, symptomatic arthritis, but until now there have been there are no validated classification criteria. This has hampered research in this ...
Calcium pyrophosphate deposition disease (CPPD) is a form of arthritis characterised by the accumulation of calcium pyrophosphate crystals within the joint cartilage and surrounding tissues. This ...
Calcium pyrophosphate crystal deposition disorders encompass a spectrum in which calcium pyrophosphate dihydrate crystals accumulate in synovial fluid, fibrocartilage and hyaline cartilage. Age ...
This article was originally published in HCPLive® and has been lightly edited. The risk of fractures is almost doubled for individuals with acute calcium pyrophosphate crystal arthritis compared to ...
In a first-of-its-kind genome-wide association study (GWAS) researchers have discovered two genes, RNF144B and ENPP1, that cause calcium pyrophosphate deposition (CPPD) disease in Americans of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results